| Cas No.: | 1445993-26-9 |
| Chemical Name: | Mivebresib |
| Synonyms: | ABBV-075;Mivebresib (ABBV-075);ABBV075;Mivebresib;VR86R11J7J;N-[4-(2,4-Difluorophenoxy)-3-(6-Methyl-7-Oxo-6,7-Dihydro-1h-Pyrrolo[2,3-C]pyridin-4-Yl)phenyl]ethanesulfonamide;N-(4-(2,4-difluorophenoxy)-3-(6-methyl-7-oxo-6,7-dihydro-1H-pyrrolo[2,3-c]pyridin-4-yl)phenyl)ethanesulfonamide;Ethanesulfonamide, N-[4-(2,4-difluorophenoxy)-3-(6,7-dihydro-6-methyl-7-oxo-1H-pyrrolo[2,3-c]pyridin-4-yl)phenyl]-;Mivebresib [INN];Ethanesulfonamide, N-(4-(2,4-difluorophenoxy)-3-(6,7-dihydro-6-methyl-7-oxo-1H-pyrro |
| SMILES: | S(C([H])([H])C([H])([H])[H])(N([H])C1C([H])=C([H])C(=C(C=1[H])C1=C([H])N(C([H])([H])[H])C(C2=C1C([H])=C([H])N2[H])=O)OC1C([H])=C([H])C(=C([H])C=1F)F)(=O)=O |
| Formula: | C22N3O4F2SH19 |
| M.Wt: | 459.4658 |
| Sotrage: | 4°C for 1 year, -20°C for more than 2 years |
| Description: | Mivebresib is a potent and orally available bromodomain and extraterminal domain (BET) bromodomain inhibitor. Mivebresib binds to BRD4 with a Ki of 1.5 nM. |
| In Vitro: | Mivebresib inhibit DHT-stimulated transcription of AR target genes without significant effect on AR protein expression. In addition to blocking the transcription activation downstream of AR, Mivebresib is also a potent inhibitor of MYC and the TMPRSS2-ETS fusion proteins[1]. |
MSDS
COA
| LOT NO. | DOWNLOAD |
|
|
|
| 2018-0101 |
|
| 2018-0101 |
|